GlassScriptPhysician profile
Hollyann D Bennett
NPI 1225594401
$2,443.53
in general payments reported to CMS, 2019-2025
20 companies · $577 in 2025
The $577 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.96 · 2022: $411 · 2023: $662 · 2024: $748 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,914 · Education: $72.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,913.51 |
| Education | $72.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $323.43 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Pfizer INC. | $278.59 | 2023-2025 | |
| Lilly USA, LLC | $257.74 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $255.91 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $240.19 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Astellas Pharma US INC | $200.42 | 2023-2025 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $116.95 | 2021-2024 | Dificid, Gardasil, Capvaxive |
| Amgen INC. | $96.04 | 2024-2025 | Repatha, Otezla, Otezla |
| Abbott Laboratories | $94.70 | 2023-2025 | Freestyle Libre 3, Infinity |
| Dexcom, INC. | $91.74 | 2024-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $91.00 | 2022-2024 | |
| Pylant Medical | $86.13 | 2023 | |
| Idorsia Pharmaceuticals US INC | $75.38 | 2023-2024 | Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $64.23 | 2022 | |
| Dynavax Technologies Corporation | $57.27 | 2022-2025 | Heplisav-B |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $37.67 | 2024 | |
| Exact Sciences Corporation | $21.03 | 2023 | Cologuard Collection Kit |
| Scilex Pharmaceuticals INC. | $20.91 | 2023 | Ztlido |
| Renalytix Ai, INC. | $18.06 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Sanofi Pasteur INC. | $16.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hollyann Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.